Regenerx Biopharma (RGRX) Receives EPO Notice of Intent to Grant Patent Related to Thymosin Beta 4

August 29, 2016 8:34 AM EDT Send to a Friend
RegeneRx Biopharmaceuticals, Inc. (OTC: RGRX) announced that it has received notice of Intent to Grant a patent from the European ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login